INTRO: Pharmaceutical giants Merck and Moderna are working on a so-called “vaccine” aimed at preventing melanoma – a popular form of skin cancer. Moderna co-founder and chairman Noubar Afeyan (NOO-barr ah-FAY-en) tells Fox Business’ “The Claman Countdown,” last year’s Phase 2 (TWO) trials show it can be more effective than at lowering the risk for cancer compared to other drugs.
ACK: Noubar Afeyan – Moderna Co-founder and Chairman
***MANDATORY CREDIT: “The Claman Countdown” on Fox Business Network***
TAG: Data from the Phase 3 (THREE) trials leaked via social media Thursday, forcing Moderna and Merck to release its results early. The incident also caused Moderna’s stock to drop nearly 20-percent that day.
KEYWORD: Politics, Business, Economy, Health
